868276463	868276463	CD	B-NP	O
|	|	NN	I-NP	O
ANMC	ANMC	NN	I-NP	O
|	|	NN	I-NP	O
49907736	49907736	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
2552510	2552510	CD	B-NP	O
|	|	CC	I-NP	O
2/17/2005	2/17/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
asthma	asthma	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/23/2005	2/23/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/9/2005	1/9/2005	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
LANESE	LANESE	NNP	B-NP	O
,	,	,	O	O
BYRON	BYRON	NNP	B-NP	O
745-53-48-1	745-53-48-1	CD	I-NP	O
Ux	Ux	NNP	I-NP	O
Li	Li	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
7/18/05	7/18/05	CD	B-NP	O
AT	AT	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
CHICAS	CHICAS	NNP	B-NP	O
,	,	,	O	O
YONG	YONG	NNP	B-NP	O
C.	C.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
DISPOSITION	DISPOSITION	NNP	I-NP	O
:	:	:	O	O
Home	Home	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ALBUTEROL	ALBUTEROL	NN	B-NP	O
INHALER	INHALER	NN	I-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
INH	INH	NN	I-NP	O
QID	QID	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
can	can	MD	B-VP	O
refuse	refuse	VB	I-VP	O
if	if	IN	B-SBAR	O
not	not	RB	O	O
SOB	SOB	NN	B-NP	B-protein
CLINDAMYCIN	CLINDAMYCIN	NN	I-NP	I-protein
HCL	HCL	NN	I-NP	I-protein
300	300	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QID	QID	NNP	I-NP	I-protein
FERROUS	FERROUS	NNP	I-NP	I-protein
SULFATE	SULFATE	NNP	I-NP	I-protein
325	325	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
TID	TID	NNP	I-NP	I-protein
Food/Drug	Food/Drug	NNP	I-NP	I-protein
Interaction	Interaction	NNP	I-NP	I-protein
Instruction	Instruction	NNP	I-NP	I-protein
Avoid	Avoid	NNP	I-NP	I-protein
milk	milk	NN	I-NP	I-protein
and	and	CC	I-NP	O
antacid	antacid	NN	I-NP	B-protein
PREDNISONE	PREDNISONE	NNP	I-NP	I-protein
Taper	Taper	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
Give	Give	NNP	I-NP	I-protein
60	60	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
q	q	NN	I-NP	I-protein
24	24	CD	I-NP	I-protein
h	h	NN	I-NP	I-protein
X	X	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
dose	dose	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
s	s	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
then	then	RB	B-ADVP	O
Give	Give	VB	B-VP	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
q	q	NN	I-NP	O
24	24	CD	I-NP	O
h	h	NN	I-NP	O
X	X	SYM	B-NP	O
2	2	CD	I-NP	O
dose	dose	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
s	s	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
Give	Give	VB	B-VP	O
30	30	CD	B-NP	O
mg	mg	NN	I-NP	O
q	q	NN	I-NP	O
24	24	CD	I-NP	O
h	h	NN	I-NP	O
X	X	SYM	B-NP	O
2	2	CD	I-NP	O
dose	dose	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
s	s	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
Give	Give	VBP	B-VP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
q	q	NN	I-NP	O
24	24	CD	I-NP	O
h	h	NN	I-NP	O
X	X	SYM	B-NP	O
2	2	CD	I-NP	O
dose	dose	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
s	s	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
then	then	RB	O	O
Give	Give	VB	B-VP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
q	q	NN	I-NP	O
24	24	CD	I-NP	O
h	h	NN	I-NP	O
X	X	SYM	B-NP	O
2	2	CD	I-NP	O
dose	dose	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
s	s	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
then	then	RB	O	O
ZOLOFT	ZOLOFT	NN	B-NP	B-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
SERTRALINE	SERTRALINE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
200	200	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
METFORMIN	METFORMIN	NNP	I-NP	I-protein
850	850	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
TID	TID	NNP	I-NP	I-protein
LEVOFLOXACIN	LEVOFLOXACIN	NNP	I-NP	I-protein
500	500	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
Food/Drug	Food/Drug	NNP	I-NP	I-protein
Interaction	Interaction	NNP	I-NP	I-protein
Instruction	Instruction	NNP	I-NP	I-protein
Administer	Administer	NNP	I-NP	I-protein
iron	iron	NN	I-NP	I-protein
products	product	NNS	I-NP	I-protein
a	a	DT	B-NP	O
minimum	minimum	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
hours	hour	NNS	I-NP	O
before	before	IN	B-PP	O
or	or	CC	I-PP	O
after	after	IN	I-PP	O
a	a	DT	B-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
or	or	CC	I-NP	O
ciprofloxacin	ciprofloxacin	NN	I-NP	O
dose	dose	NN	I-NP	O
dose	dose	NN	I-NP	O
If	If	IN	B-SBAR	O
on	on	IN	B-PP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
cycle	cycle	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
hold	hold	VBP	B-VP	O
1	1	CD	B-NP	O
hr	hr	NN	I-NP	O
before	before	IN	B-PP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
hr	hr	NN	I-NP	O
after	after	IN	B-PP	O
-RRB-	-RRB-	NN	B-NP	B-protein
Take	Take	NN	I-NP	I-protein
2	2	CD	B-NP	I-protein
hours	hour	NNS	I-NP	I-protein
before	before	IN	B-PP	O
or	or	CC	B-NP	O
2	2	CD	I-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
dairy	dairy	NN	B-NP	O
products	product	NNS	I-NP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/3/05	10/3/05	CD	B-NP	O
by	by	IN	B-PP	O
HISER	HISER	NN	B-NP	B-protein
,	,	,	O	O
ALAN	ALAN	NNP	B-NP	O
B.	B.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.S.C.	M.S.C.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SALMETEROL	SALMETEROL	NNP	B-NP	O
XINAFOATE	XINAFOATE	NNP	I-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
Will	Will	NNP	B-NP	O
monitor	monitor	NNP	I-NP	O
ADVAIR	ADVAIR	NNP	I-NP	O
DISKUS	DISKUS	NNP	I-NP	O
250/50	250/50	CD	I-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
FLUTICASONE	FLUTICASONE	NN	I-NP	O
PROPIONATE	PROPIONATE	NN	I-NP	O
/	/	SYM	B-NP	O
...	...	:	O	B-protein
-RRB-	-RRB-	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
PUFF	PUFF	NN	I-NP	I-protein
INH	INH	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/3/05	10/3/05	CD	B-NP	O
by	by	IN	B-PP	O
GAZDA	GAZDA	NNP	B-NP	B-protein
,	,	,	O	O
JAY	JAY	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.S.C.	M.S.C.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
24519808	24519808	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SALMETEROL	SALMETEROL	NNP	B-NP	O
XINAFOATE	XINAFOATE	NNP	I-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
Will	Will	NNP	B-NP	O
monitor	monitor	NNP	I-NP	O
LASIX	LASIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Dangler	Dangler	NNP	I-NP	O
July	July	NNP	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
:	:	SYM	I-NP	O
50	50	CD	I-NP	O
pm	pm	NN	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
asthma	asthma	NN	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NN	B-NP	O
for	for	IN	B-PP	O
Causing	Cause	VBG	B-VP	O
Admission	Admission	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
asthma	asthma	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
asthma	asthma	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
asthma	asthma	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
niddm	niddm	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
type	type	NN	I-NP	O
2	2	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NN	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	VBZ	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
SOB	SOB	NN	B-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
36	36	CD	I-NP	O
yo	yo	NN	I-NP	O
woman	woman	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
asthma	asthma	NN	B-NP	O
and	and	CC	I-NP	O
obestity	obestity	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
SOB	SOB	NN	B-NP	B-protein
and	and	CC	I-NP	O
URI	URI	NN	I-NP	O
sx	sx	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
previously	previously	RB	I-VP	O
been	be	VBN	I-VP	O
hospitalized	hospitalize	VBN	I-VP	O
for	for	IN	B-PP	O
asthma	asthma	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
never	never	RB	B-VP	O
intubated	intubate	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
never	never	RB	I-VP	O
required	require	VBN	I-VP	O
ICU	ICU	NN	B-NP	O
care	care	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
last	last	JJ	B-ADJP	O
treated	treat	VBN	B-VP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
asthma	asthma	NN	I-NP	O
flare	flare	NN	I-NP	O
one	one	CD	B-NP	O
month	month	NN	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
refill	refill	VB	I-VP	O
her	her	PRP$	B-NP	O
advair	advair	NN	I-NP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
social	social	JJ	B-NP	O
pressures	pressure	NNS	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
children	child	NNS	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

She	She	PRP	B-NP	O
works	work	VBZ	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
pre	pre	AFX	I-NP	B-DNA
-	-	HYPH	I-NP	O
school	school	NN	I-NP	O
teacher	teacher	NN	I-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
in	in	IN	B-PP	O
frequent	frequent	JJ	B-NP	O
contact	contact	NN	I-NP	O
with	with	IN	B-PP	O
sick	sick	JJ	B-NP	O
children	child	NNS	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
week	week	NN	I-NP	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
increasing	increase	VBG	B-NP	O
SOB	SOB	NN	I-NP	B-protein
,	,	,	O	O
cough	cough	NN	B-NP	O
productive	productive	JJ	B-ADJP	O
of	of	IN	B-PP	O
white	white	JJ	B-NP	O
sputum	sputum	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
DOE	DOE	NNP	B-NP	O
after	after	IN	B-PP	O
1	1	CD	B-NP	O
block	block	NN	I-NP	O
.	.	.	O	O

Peak	Peak	NN	B-NP	O
flow	flow	NN	I-NP	O
about	about	IN	B-PP	O
450	450	CD	B-NP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
,	,	,	O	O
250	250	CD	B-NP	O
today	today	NN	B-NP	O
.	.	.	O	O

Seen	Seen	NN	B-NP	O
in	in	IN	B-PP	O
urgent	urgent	JJ	B-NP	O
care	care	NN	I-NP	O
and	and	CC	O	O
found	find	VBN	B-VP	O
to	to	TO	I-VP	O
de-sat	de-sat	VB	I-VP	O
to	to	TO	B-PP	O
85	85	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
RA	RA	NN	B-NP	O
on	on	IN	B-PP	O
ambulation	ambulation	NN	B-NP	O
.	.	.	O	O

Referred	Refer	VBN	B-VP	O
to	to	TO	B-PP	O
ED	ED	NN	B-NP	O
.	.	.	O	O

There	There	RB	B-ADVP	O
,	,	,	O	O
VS	VS	VBZ	B-VP	O
96.1	96.1	CD	B-NP	O
97149/75	97149/75	CD	I-NP	O
20	20	CD	I-NP	O
89	89	CD	I-NP	O
on	on	IN	B-PP	O
RA	RA	NN	B-NP	B-protein
.	.	.	O	O

Treated	Treat	VBN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
nebs	neb	NNS	I-NP	O
,	,	,	O	O
prednisone	prednisone	NN	B-NP	O
,	,	,	O	O
lasix	lasix	CD	B-NP	O
for	for	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
congestion	congestion	NN	I-NP	O
seen	see	VBN	B-VP	O
on	on	IN	B-PP	O
CXR	CXR	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
levofloxacin	levofloxacin	NN	B-NP	O
for	for	IN	B-PP	O
possible	possible	JJ	B-NP	O
RLL	RLL	NN	I-NP	O
infiltrate	infiltrate	NN	I-NP	O
on	on	IN	B-PP	O
CXR	CXR	NN	B-NP	B-protein
.	.	.	O	O

ROS	ROS	NN	B-NP	O
:	:	:	O	O
postive	postive	JJ	B-ADJP	O
for	for	IN	B-PP	O
lightheadedness	lightheadedness	NN	B-NP	O
,	,	,	O	O
blurred	blur	VBD	B-VP	O
vision	vision	NN	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
fluttering	fluttering	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
h/o	h/o	NN	I-NP	O
calf	calf	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

PMH	PMH	NN	B-NP	O
:	:	:	O	O
Asthma	Asthma	NN	B-NP	O
,	,	,	O	O
NIDDM	NIDDM	NN	B-NP	B-protein
,	,	,	O	O
s/p	s/p	NN	B-NP	O
c-section	c-section	NN	I-NP	O
,	,	,	O	O
tubal	tubal	JJ	B-NP	O
ligation	ligation	NN	I-NP	O
,	,	,	O	O
teratoma	teratoma	NN	B-NP	O
removal	removal	NN	I-NP	O
.	.	.	O	O

Meds	Med	NNS	B-NP	O
:	:	:	O	O
Albuterol	Albuterol	NN	B-NP	O
,	,	,	O	O
atrovent	atrovent	NN	B-NP	O
,	,	,	O	O
metformin	metformin	NN	B-NP	O
,	,	,	O	O
zoloft	zoloft	NN	B-NP	O
,	,	,	O	O
advair	advair	NN	B-NP	O
All	All	NNP	I-NP	O
:	:	:	O	O
NKDA	NKDA	NNP	B-NP	O
Soc	Soc	NNP	I-NP	O
Hx	Hx	NNP	I-NP	O
:	:	:	O	O
Married	Married	NNP	B-NP	O
,	,	,	O	O
two	two	CD	B-NP	O
children	child	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
tob	tob	NN	I-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
Etoh	Etoh	NNP	I-NP	O
Fam	Fam	NNP	I-NP	O
Hx	Hx	NNP	I-NP	O
:	:	:	O	O
PE	PE	NN	B-NP	O
,	,	,	O	O
father	father	NN	B-NP	O
Admission	Admission	NNP	I-NP	O
exam	exam	NN	I-NP	O
:	:	:	O	O
96.4	96.4	CD	B-NP	O
79140/90	79140/90	CD	I-NP	O
20	20	CD	I-NP	O
97	97	CD	I-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
Obese	Obese	JJ	I-NP	O
woman	woman	NN	I-NP	O
,	,	,	O	O
speaking	speak	VBG	B-VP	O
in	in	IN	B-PP	O
complete	complete	JJ	B-NP	O
sentences	sentence	NNS	I-NP	O
,	,	,	O	O
NAD	NAD	NN	B-NP	O
.	.	.	O	O

RRR	RRR	NN	B-NP	B-protein
no	no	DT	B-NP	O
MGR	MGR	NN	I-NP	B-protein
.	.	.	O	O

Mild	Mild	NNP	B-NP	O
rhonchi	rhonchus	NNS	I-NP	O
at	at	IN	B-PP	O
RLL	RLL	NN	B-NP	O
,	,	,	O	O
otherwise	otherwise	RB	B-NP	O
infrequent	infrequent	JJ	I-NP	O
wheezing	wheezing	NN	I-NP	O
.	.	.	O	O

+	+	SYM	O	O
BS	BS	NNP	B-NP	O
s	s	NNS	I-NP	O
,	,	,	O	O
nt	nt	NN	B-NP	O
,	,	,	O	O
nd	nd	NN	B-NP	O
.	.	.	O	O

1	1	CD	B-NP	O
+	+	SYM	I-NP	O
edema	edema	NN	I-NP	O
in	in	IN	B-PP	O
le	le	NN	B-NP	O
's	's	POS	B-NP	O
,	,	,	O	O
ulcer	ulcer	NN	B-NP	O
on	on	IN	B-PP	O
R	R	NN	B-NP	O
shin	shin	NN	I-NP	O
w/erythema	w/erythema	NN	I-NP	O
tracking	track	VBG	B-VP	O
down	down	IN	B-PP	O
leg	leg	NN	B-NP	O
.	.	.	O	O

Neuro	Neuro	NN	B-NP	O
non-focal	non-focal	JJ	B-ADJP	O
.	.	.	O	O

Labs	Lab	NNS	B-NP	O
:	:	:	O	O
Nl	Nl	NNP	B-NP	B-cell_type
Chem	Chem	NNP	I-NP	O
7	7	CD	I-NP	O
.	.	.	O	O

WBC	WBC	NN	B-NP	O
9.3	9.3	CD	I-NP	O
HCT	HCT	NN	I-NP	O
31	31	CD	B-NP	O
Plt	Plt	NNP	I-NP	O
289	289	CD	I-NP	O
D-dimer	D-dimer	NN	I-NP	O
1132	1132	CD	B-NP	O
A/P	A/P	NN	I-NP	O
:	:	:	O	O
36	36	CD	B-NP	O
yo	yo	NN	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
h/o	h/o	NN	B-NP	O
asthma	asthma	NN	I-NP	O
,	,	,	O	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
SOB	SOB	NN	B-NP	B-protein
,	,	,	O	O
URI	URI	NN	B-NP	O
sx	sx	NN	I-NP	O
,	,	,	O	O
de-sat	de-sat	NN	B-NP	O
on	on	IN	B-PP	O
ambulation	ambulation	NN	B-NP	O
.	.	.	O	O

Asthma	Asthma	NNP	B-NP	O
flare	flare	VBP	B-VP	O
most	most	RBS	B-ADVP	O
likely	likely	RB	I-ADVP	O
,	,	,	O	O
though	though	IN	B-SBAR	O
d-dimer	d-dimer	NN	B-NP	O
concerning	concern	VBG	B-VP	O
for	for	IN	B-PP	O
DVT/PE	DVT/PE	NN	B-NP	O
.	.	.	O	O

Hospital	Hospital	NNP	B-NP	O
Course	Course	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
albuterol/advair	albuterol/advair	NN	B-NP	O
nebulizers	nebulizer	NNS	I-NP	O
and	and	CC	O	O
prednisone	prednisone	NN	B-NP	O
with	with	IN	B-PP	O
rapid	rapid	JJ	B-NP	O
improvement	improvement	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
Advair	Advair	NNP	B-NP	O
,	,	,	O	O
and	and	CC	O	O
written	write	VBN	B-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
prednisone	prednisone	NN	I-NP	O
taper	taper	NN	I-NP	O
for	for	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

LENIS	LENIS	NNS	B-NP	B-protein
were	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
which	which	WDT	B-NP	O
excluded	exclude	VBD	B-VP	O
the	the	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
DVT	DVT	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
hypoxia	hypoxia	NN	I-NP	O
and	and	CC	O	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
complain	complain	VB	I-VP	O
of	of	IN	B-PP	O
pleuritic	pleuritic	JJ	B-NP	B-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
PE	PE	NN	B-NP	O
is	be	VBZ	B-VP	O
low	low	JJ	B-NP	O
probability	probability	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
40mg	40mg	NN	B-NP	O
IV	IV	CD	I-NP	O
lasix	lasix	NN	I-NP	O
for	for	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
seen	see	VBN	B-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
CXR	CXR	NN	I-NP	B-protein
.	.	.	O	O

Her	Her	PRP$	B-NP	O
BNP	BNP	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
24	24	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
makes	make	VBZ	B-VP	O
systolic	systolic	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
unlikely	unlikely	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
recent	recent	JJ	I-NP	O
ECHO	ECHO	NN	I-NP	O
shows	show	VBZ	B-VP	O
EF	EF	NN	B-NP	B-protein
60	60	CD	I-NP	I-protein
%	%	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

She	She	PRP	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpt	outpt	NN	I-NP	O
for	for	IN	B-PP	O
serial	serial	JJ	B-NP	O
examinations	examination	NNS	I-NP	O
and	and	CC	O	O
placed	place	VBN	B-VP	O
on	on	IN	B-PP	O
lasix	lasix	NN	B-NP	O
if	if	IN	B-SBAR	O
she	she	PRP	B-NP	O
continues	continue	VBZ	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
signs	sign	NNS	B-NP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
suggesting	suggest	VBG	B-VP	O
diastolic	diastolic	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
.	.	.	O	O

Finally	Finally	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
+	+	SYM	I-NP	O
clindamycin	clindamycin	NN	I-NP	O
as	as	IN	B-PP	O
coverage	coverage	NN	B-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
LE	LE	NN	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
and	and	CC	O	O
RLL	RLL	NN	B-NP	O
infiltrate	infiltrate	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
encouraged	encourage	VBN	I-VP	O
to	to	TO	I-VP	O
lose	lose	VB	I-VP	O
weight	weight	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
to	to	TO	B-VP	O
obtain	obtain	VB	I-VP	O
nutrition	nutrition	NN	B-NP	O
consultation	consultation	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
plan	plan	NN	I-NP	O
for	for	IN	B-PP	O
exercise	exercise	NN	B-NP	O
to	to	TO	B-VP	O
achieve	achieve	VB	I-VP	O
this	this	DT	B-NP	O
aim	aim	NN	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
had	have	VBD	I-VP	O
a	a	DT	B-NP	O
viral	viral	JJ	I-NP	O
infection	infection	NN	I-NP	O
that	that	WDT	B-NP	O
worsened	worsen	VBD	B-VP	O
your	your	PRP$	B-NP	O
asthma	asthma	NN	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
should	should	MD	B-VP	O
take	take	VB	I-VP	O
Advair	Advair	NNP	B-NP	O
daily	daily	RB	B-ADVP	O
and	and	CC	O	O
albuterol	albuterol	NN	B-NP	O
only	only	RB	B-ADVP	O
as	as	IN	B-SBAR	O
you	you	PRP	B-NP	O
need	need	VBP	B-VP	O
it	it	PRP	B-NP	O
for	for	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

you	you	PRP	B-NP	O
are	be	VBP	B-VP	O
being	be	VBG	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
for	for	IN	B-PP	O
10	10	CD	B-NP	O
days	day	NNS	I-NP	O
for	for	IN	B-PP	O
your	your	PRP$	B-NP	O
leg	leg	NN	I-NP	O
skin	skin	NN	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
should	should	MD	B-VP	O
keep	keep	VB	I-VP	O
your	your	PRP$	B-NP	O
leg	leg	NN	I-NP	O
elevated	elevate	VBD	B-VP	O
as	as	RB	B-NP	O
much	much	JJ	I-NP	O
as	as	IN	B-PP	O
possible	possible	JJ	B-ADJP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
10	10	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
should	should	MD	B-VP	O
work	work	VB	I-VP	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
to	to	TO	B-VP	O
help	help	VB	I-VP	O
lose	lose	VB	I-VP	O
weight	weight	NN	B-NP	O
to	to	TO	B-VP	O
improve	improve	VB	I-VP	O
your	your	PRP$	B-NP	O
breathing	breathing	NN	I-NP	O
,	,	,	O	O
fluid	fluid	NN	B-NP	O
retention	retention	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
diabetes	diabetes	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

take	take	VB	B-VP	O
advair	advair	NN	B-NP	O
as	as	IN	B-PP	O
scheduled	schedule	VBN	B-NP	B-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

f/u	f/u	NN	B-NP	O
wt	wt	NN	I-NP	O
gain	gain	NN	I-NP	O
with	with	IN	B-PP	O
pcp	pcp	NN	B-NP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
SHAMSIDDEEN	SHAMSIDDEEN	NNP	B-NP	O
,	,	,	O	O
CLAUDE	CLAUDE	NNP	B-NP	O
L.	L.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.S.C.	M.S.C.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
HA66	HA66	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
7/18/05	7/18/05	CD	I-NP	O
@	@	SYM	B-NP	O
01	01	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

